RENEE GIROUARD: Open Payments
NPI 1396374732 · SEVIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 15 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $1,373 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $61 |
| Novo Nordisk Inc | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: GEMTESA, NUZYRA, XIFAXAN, CREON, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, Wegovy.
Industry payments across TN — which companies pay providers there.
